Drugs News and Research

RSS

CPF, PFF applaud PF patients' efforts to plead with FDA Advisory Panel regarding lack of treatment options

The Coalition for Pulmonary Fibrosis and the Pulmonary Fibrosis Foundation are applauding the efforts of Pulmonary Fibrosis (PF) patients and family members for their work to convey to the FDA and an FDA Advisory Committee the sense of urgency and desperation regarding the disease and the lack of treatment options.

15 Mar 2010

Researchers discover microtentacles that play key role in spreading cancer to distant locations in body

Researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center have discovered that "microtentacles," or extensions of the plasma membrane of breast cancer cells, appear to play a key role in how cancers spread to distant locations in the body. Targeting these microtentacles might prove to be a new way to prevent or slow the growth of these secondary cancers, the scientists say.

15 Mar 2010

Bone implants that support and release chemotherapeutical agents in ciclodextrin nanocapsule

Chemotherapy, followed by the surgical removal of the affected tissue is the treatment usually adapted to bone tumors. An implant which can fill the areas of subtraction, while releasing chemotherapeutical agents locally, in a controlled manner, during the treatment period, is the aim of a research led by the Research Centre in Ceramic Material and Composites (CICECO/UA). In these experiences, specialists are using potential "anti-tumor" drugs coated by nanocapsules.

15 Mar 2010

NCCN Guidelines and impact of escalating health care costs highlighted at NCCN Annual Conference

The escalating costs of cancer care combined with variations in concordance with evidence-based practice guidelines is putting the United States on a collision course for an impending collapse of its current health care system according to roundtable panelists at the NCCN 15th Annual Conference.

15 Mar 2010

Older patients receive potentially inappropriate medications when treated in emergency room: Study

A University of Michigan study recently published in Academic Emergency Medicine says that it is common for patients 65 and older to receive potentially inappropriate medications when treated in an emergency room.

15 Mar 2010

MPP cell population: A new potential target for treating infections and allergies

Millions of people in both the developing and developed world may benefit from new immune-system research findings from the University of Pennsylvania School of Veterinary Medicine.

15 Mar 2010

Ipsen commences dosing in two BIM 23A760 phase II studies for neuroendocrine tumors and acromegaly

Ipsen announced today the initiation of dosing in two phase II clinical studies to evaluate efficacy and safety of BIM 23A760 in two groups of patients, one suffering from carcinoid syndrome due to neuroendocrine tumors, the other from acromegaly.

15 Mar 2010

Montana Gov. seeks to buy state's prescription drugs from Canada; Settlement reached for ground zero workers

"Gov. Brian Schweitzer [D-Mont.] said Thursday that he is seeking federal permission to import cheaper drugs from Canada for use in state insurance programs," The Associated Press/The New York Times reports

15 Mar 2010

New laboratory technique may help prioritize cancer drugs for clinical trials

Improving on traditional screening tests for potential anti-cancer drugs, scientists at Dana-Farber Cancer Institute have developed a laboratory technique that more closely simulates the real-world conditions in which tumor cells mingle with the body's normal cells.

15 Mar 2010

New findings shed light on how genetic damage to muscle cell proteins can lead to nemaline myopathy

New findings that shed light on how genetic damage to muscle cell proteins can lead to the development of the rare muscle-wasting disease, nemaline myopathy, are reported today (15 March) in the Biochemical Journal.

15 Mar 2010

CCIH study: Canadians are forced to choose between personal health and financial future

Canadians are increasingly being forced to choose between their personal health and their financial future, according to a study released today by the Canadian Council for Integrated Healthcare.

15 Mar 2010

New PEGylated Polylysine dendrimers: Benefits patients with cancer, HIV and lymphatic conditions

Monash Institute of Pharmaceutical Science researchers, in collaboration with the biotechnology company Starpharma Holdings Ltd have developed a new method to deliver medications that may benefit thousands of patients with particular types of cancer, HIV and lymphatic conditions world-wide.

15 Mar 2010

Two controlled environmental variables to preclinical mice tests can reduce costly false positives: Study

For decades, the traditional practice in animal testing has been standardization, but a study involving Purdue University has shown that adding as few as two controlled environmental variables to preclinical mice tests can greatly reduce costly false positives, the number of animals needed for testing and the cost of pharmaceutical trials.

15 Mar 2010

Discovery of MiR-451 molecule may serve as a biomarker for brain tumor

Cancer cells in rapidly growing brain tumors must adjust to periods of low energy or die. When energy levels are high, tumor cells grow and proliferate. When levels are low, the cells grow less and migrate more.

15 Mar 2010

Bio-Path Holdings' liposomal Grb-2 IND receives FDA clearance to proceed into clinical trials

Bio-Path Holdings, Inc., a publicly traded biotechnology company with drug development operations in Houston, Texas, announced today that the U.S. Food and Drug Administration has allowed an IND (Investigational New Drug) for the Company’s lead cancer drug candidate liposomal Grb-2 to proceed into clinical trials.

15 Mar 2010

States face health spending cuts

President Obama's demand to delete 'special deals' in the health care package would eliminate $500 million in extra Medicaid cash for Massachusetts, but Bay State lawmakers say they are confident the state would recoup that and probably more once negotiations are complete.

12 Mar 2010

UVA, Merck collaborate to discover novel drugs for women's reproductive health

The University of Virginia in Charlottesville today announced that it has entered into a research collaboration with Merck (known as MSD outside the United States and Canada) to discover novel drugs for women's reproductive health.

12 Mar 2010

$Bisphosphonate treatments may affect bone quality and increase risk of atypical fractures of femur$

Bisphosphonate treatments may affect bone quality and increase risk of atypical fractures of femur

Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons.

12 Mar 2010

Arena Pharmaceuticals reports lower net loss allocable to common stockholders in fourth-quarter 2009

Arena Pharmaceuticals, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2009.

12 Mar 2010

StockPreacher.com announces investment report featuring Generex Biotechnology

StockPreacher.com announces an investment report featuring Generex Biotechnology Corp. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

12 Mar 2010

Drugs News and Research

CPF, PFF applaud PF patients' efforts to plead with FDA Advisory Panel regarding lack of treatment options

Researchers discover microtentacles that play key role in spreading cancer to distant locations in body

Bone implants that support and release chemotherapeutical agents in ciclodextrin nanocapsule

NCCN Guidelines and impact of escalating health care costs highlighted at NCCN Annual Conference

Older patients receive potentially inappropriate medications when treated in emergency room: Study

MPP cell population: A new potential target for treating infections and allergies

Ipsen commences dosing in two BIM 23A760 phase II studies for neuroendocrine tumors and acromegaly

Montana Gov. seeks to buy state's prescription drugs from Canada; Settlement reached for ground zero workers

New laboratory technique may help prioritize cancer drugs for clinical trials

New findings shed light on how genetic damage to muscle cell proteins can lead to nemaline myopathy

CCIH study: Canadians are forced to choose between personal health and financial future

New PEGylated Polylysine dendrimers: Benefits patients with cancer, HIV and lymphatic conditions

Two controlled environmental variables to preclinical mice tests can reduce costly false positives: Study

Discovery of MiR-451 molecule may serve as a biomarker for brain tumor

Bio-Path Holdings' liposomal Grb-2 IND receives FDA clearance to proceed into clinical trials

States face health spending cuts

UVA, Merck collaborate to discover novel drugs for women's reproductive health

Bisphosphonate treatments may affect bone quality and increase risk of atypical fractures of femur

Arena Pharmaceuticals reports lower net loss allocable to common stockholders in fourth-quarter 2009

StockPreacher.com announces investment report featuring Generex Biotechnology

Drug Discovery - Second Edition eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News